Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is that treatments like finasteride and minoxidil can prevent baldness progression and improve hair density, but more research is needed on other therapies.

Melatonin receptors, found in many body parts, can help treat various diseases like depression and diabetes due to their effects on inflammation, tumor progression, sleep disorders, and body mass regulation.

Healthy aging can be promoted through physical activity, lifestyle changes, and certain treatments.

Combining flutamide and finasteride can reduce prostate weight and tumor growth, potentially benefiting treatments needing optimal DHT inhibition.

Androgens may influence T cells, contributing to higher autoimmune liver disease risk in women.

New treatments are making advanced prostate cancer management more complex but also more hopeful.

5α-reductase inhibitors can cause sexual problems, higher risk of aggressive prostate cancer, and depression.

The document concludes that targeting the androgen receptor may be a promising breast cancer treatment, especially for certain types.

Androgens increase a growth factor in hair cells by creating reactive oxygen species, and antioxidants might help treat hair loss.

Doxil showed some effectiveness against advanced prostate cancer but caused severe side effects at higher doses.

Finasteride might lower the risk of low-grade prostate cancer but not high-grade cancer, while alpha-blockers might reduce high-grade cancer risk.

Higher DHT in male baldness may protect against prostate cancer.

Androgen receptor signaling causes early aging of cells important for hair growth by damaging their DNA.

TGF-β1 increases androgen receptor activity in hair loss, but Hic-5/ARA55 can counter this effect.

Polygonum multiflorum extract helps hair grow longer and fights the effects of hormones that cause hair loss.

A new compound was effective for imaging prostate cancer in rats.

Certain plasma proteins are linked to prostate cancer risk and could help in early detection and treatment.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

Androgens may cause hair loss by increasing TGF-beta1 from scalp cells, which inhibits hair cell growth.

Runx1 controls fat-related genes important for normal and cancer cell growth, affecting skin and hair cell behavior.

Age, race, family history, and certain genetic factors increase prostate cancer risk.

Men with baldness at the front and top of their head at age 45 may have a higher risk of aggressive prostate cancer.

MENT could be a better option than testosterone for male hormone therapy and birth control because it works well at lower doses and has fewer side effects on the prostate.

Excess maternal androgens can cause heart problems in offspring.

The research found that androgens help control blood flow in the rat prostate through a specific binding site.

Men with a certain baldness pattern at age 40-50 may have a higher risk of aggressive prostate cancer.

Men with male pattern baldness have a higher risk of dying from prostate cancer.

Genetic differences within ethnic groups may affect prostate cancer treatment effectiveness.

Higher cholesterol levels increase aggressive prostate cancer risk.

Dutasteride may help shrink prostate cancer tumors.